Trial Profile
Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia -A Multicenter,Randomized, Double-blind, Placebo-controlled Trial
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Feb 2018
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Postherpetic neuralgia
- Focus Therapeutic Use
- Acronyms EASOPSRTFP
- Sponsors Jiangsu Hengrui Medicine Co.
- 26 Aug 2016 New trial record